Mission
TO HELP CONQUER CANCER AND OTHER DISEASES THROUGH THE APPLICATION OF BIOSTATISTICAL PRINCIPLES AND INNOVATIVE DATA MANAGEMENT METHODS.
Public Charity
CANCER RESEARCH AND BIOSTATISTICS
CANCER RESEARCH AND BIOSTATISTICS, of SEATTLE, WA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2024 filing shows $11.3M in revenue, $11.7M in expenses, $9.9M in total assets. 22 publicly reported grants to this organization, totaling roughly $64.1M, appear in IRS filings.
EIN: 911828539
SEATTLE, WA
Cancer Research
NTEE: H30
Latest filing: 2024
Total Revenue$11.3M
Total Expenses$11.7M
Total Assets$9.9M
Grant Records22
Funding Total$64.1M
Filing Years2019–2024
Where $100 goes at Cancer Research and Biostatistics
How Cancer Research and Biostatistics divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$70
Programs
the work itself
$30
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $70 for programs
$70
Cancer research & biostatistics (crab) is a national leader in designing and managing oncology clinical trials
<$1
In 2024, crab continued to provide ongoing support through excellent training to early investigators and clinical research associates
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
SWOG LATIN AMERICA INITIATIVE
$188,731
Research Support/Subawards
$7,759,677
HOPE SDMC BRIDGE AWARD
$250,000
SWOG LATIN AMERICA INITIATIVE
$149,934
RESEARCH SUPPORT/SUBAWARDS
$7,589,422
Showing up to 5 of 22 total records — full history available with membership.
Officers & Directors
DIRECTOR
Alvendia Melissa
CTO, SECRETARY
Cook Christopher
DIRECTOR, CHIEF OF STRATEGIC ALLIANCES
Crowley John
DIRECTOR
Cummins Tim
DIRECTOR
Curci Frank
DIRECTOR
Davis Roderic
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $11.3M | $11.7M | $9.9M |
| 2023 | $12.1M | $12.5M | $11.5M |
| 2022 | $12.2M | $12.1M | $12.4M |
| 2020 | $12.6M | $11.3M | $8.8M |
| 2019 | $12.8M | $12.2M | $7.4M |
Between 2019 and 2024, reported annual revenue declined from $12.8M to $11.3M (-11%), with total assets most recently reported at $9.9M.
Interactive year-over-year charts and full filing details available with membership.